Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from Canada to the United States. The cannabis was imported in support of a clinical trial related to that of breast cancer research.

Specifically, the study is researching the impact that medical cannabis has on individuals that have breast cancer while also suffering from taxane-induced peripheral neuropathy (TIPN). Patients that have TIPN are typically not able to utilize chemotherapy to treat breast cancer to the same extent that those without the disorder are.

Within the study, a randomized group of patients suffering from TIPN will be given a twice daily dosage of active cannabinoids in the form of THC and CBD for eight weeks, while a control group will be given a placebo. It is unclear as to what form of delivery will be used for the cannabinoids within the study.

We’re excited to support this groundbreaking, first-of-its-kind trial seeking to find a new treatment option for TIPN. Tilray is committed to advancing cannabis research through its support of clinical trials around the world as we continue to enhance our understanding of the potential benefits of medical cannabis.

Philippe Lucas, Tilray’s Vice President of Global Patient Research and Access

There are currently no effective treatments for TIPN on the markets, a disorder which effects approximately 67% of women underoing breast cancer treatment. However, early studies conducted on mice with medical cannabis provided positive results in the treatment of TIPN. The research that Tilray is involved within is the first human trial of utilizing medical cannabis to treat the disorder.

Tilray closed yesterday’s session at $22.63 on the Nasdaq.


Information for this briefing was found via Sedar and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Tilray: Canaccord Cuts Price Target To $9.00

On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results, the company...

Tuesday, January 11, 2022, 04:22:00 PM

Federal Wage Subsidies Granted to Publicly Traded Cannabis Companies Eclipses $100 Million

On June 1, 2021, total wage subsidies doled out to publicly traded cannabis companies from...

Wednesday, June 2, 2021, 02:30:00 PM

Tilray Closes Purchase Of Molson Coors’ Interest In Truss Beverage

Tilray Brands (TSX: TLRY) has finally closed on its acquisition of Truss Beverage Co. The...

Wednesday, January 24, 2024, 08:14:30 AM

Tilray To Acquire 8 Anheuser-Busch Beverage Brands For $85 Million

Tilray Brands (NASDAQ: TLRY) has revealed its engagement in a definitive agreement to acquire eight...

Tuesday, August 8, 2023, 09:21:24 AM

Tilray Brands Q3 Earnings Analysis: Behind The CEO’s “Robust” Claims

“Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning...

Saturday, April 12, 2025, 03:28:00 PM